As nations globally fight the coronavirus, there’s another public health issue that countries are tackling – the opioid epidemic. In the US alone, the over-prescription of opioids is costing the healthcare system over $500bn and to date approximately 120-150 deaths per day can be attributed to opioid overdose issues. However, this is not just a US problem, opioid addiction is becoming an increasing problem in Europe too. To fight this crisis, save lives and reduce costs, health officials are looking towards innovative implanted neuromodulation devices.
To discuss the challenges facing product designers of these next-generation devices, we talk to experts Dr Krishnan Chakravarthy, CEO and Founder of NXTStim and Rahul Saini, COO and Founder of Teliatry.
Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.